Global Pathology Analysis & Statistics, January 2015 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

31-60 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

IVD (In Vitro Diagnostic) Testing World Markets

IVD (In Vitro Diagnostic) Testing World Markets

  • $ 4 500
  • Industry report
  • January 2015
  • by TriMark Publications

In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic, Medical Devices
  • Countries : World
World Digital Pathology Systems Industry

World Digital Pathology Systems Industry

  • $ 4 500
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...

  • Industries : Pathology
  • Countries : World, Europe
Sleep Apnea Devices Market by Segments - Global Forecast to 2019

Sleep Apnea Devices Market by Segments - Global Forecast to 2019

  • $ 4 250
  • Industry report
  • February 2015
  • by Micro Market Monitor

The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with ...

  • Industries : Pathology, General Medicine and Specialty Medicine
  • Countries : World
EpiCast Report: Insomnia - Epidemiology Forecast to 2023

EpiCast Report: Insomnia - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2015
  • by Global Data

EpiCast Report: Insomnia - Epidemiology Forecast to 2023 Summary GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent ...

  • Industries : Pathology
  • Countries : Japan, World, Italy, Europe, France
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023

EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2015
  • by Global Data

EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 Summary Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is characterized by an irregular heart ...

  • Industries : Pathology
  • Countries : Japan, World, United Kingdom, Germany, Spain
IVD Procedure Volumes and Pricing Analysis

IVD Procedure Volumes and Pricing Analysis

  • $ 3 995
  • Industry report
  • January 2015
  • by Kalorama Information

Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. In addition to ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic
  • Countries : World
Diabetes - World Panorama

Diabetes - World Panorama

  • $ 3 750
  • Industry report
  • March 2015
  • by Expernova

Diabetes is an abnormally raised level of glucose in the blood. If left untreated, diabetes can be serious and can cause heart disease, blindness, impotence or even amputation. Treatment of this disease ...

  • Industries : Pathology
  • Countries : World
Biomarker - World Panorama

Biomarker - World Panorama

  • $ 3 750
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : World
Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World
Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical
  • Countries : World
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical
  • Countries : World
Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology, Biotechnology
  • Countries : World
Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World
Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Diabetes - European Panorama

Diabetes - European Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

Diabetes is an abnormally raised level of glucose in the blood. If left untreated, diabetes can be serious and can cause heart disease, blindness, impotence or even amputation. Treatment of this disease ...

  • Industries : Pathology
  • Countries : Europe
Diabetes - North American Panorama

Diabetes - North American Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

Diabetes is an abnormally raised level of glucose in the blood. If left untreated, diabetes can be serious and can cause heart disease, blindness, impotence or even amputation. Treatment of this disease ...

  • Industries : Pathology
  • Countries : North America
Diabetes - Asian Panorama

Diabetes - Asian Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

Diabetes is an abnormally raised level of glucose in the blood. If left untreated, diabetes can be serious and can cause heart disease, blindness, impotence or even amputation. Treatment of this disease ...

  • Industries : Pathology
  • Countries : Asia
Biomarker - European Panorama

Biomarker - European Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Europe
Biomarker - North American Panorama

Biomarker - North American Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : North America
Biomarker - Asian Panorama

Biomarker - Asian Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Asia
Global Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing ...

  • Industries : Therapy, Pathology
  • Countries : World
Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About Acquired Orphan Blood Diseases Therapeutics Acquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically ...

  • Industries : Pathology, Therapy
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.